Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The presence of nodal metastasis is one of the most important predictive factors for recurrence after radical surgery for nonfunctioning Pancreatic Neuroendocrine Neoplasms (NF-PanNEN). Nevertheless, it is not clear which is the best diagnostic examination to identify preoperatively lymphnodal metastasis.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Giannone F
Authors: Giannone F, Muffatti F, Partelli S, Andreasi V, Guarneri G,
Keywords: imaging, lymph node, metastases,
Introduction: Lanreotide is a long-acting somatostatin analogue with proven antitumor effect against metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors (GEP-NETs). Ga-68-DOTATOC PET/CT is a sensitive imaging technique for NETs by targeting somatostatin receptors.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Kim Y, Yoo C, Ryoo B, Ryu J,
Keywords: neuroendocrine tumor, lanreotide, somatostatin receptor, DOTATOC, positron emission tomography, prognosis,
Introduction: The degree of overexpression of somatostatin receptors in patients with neuroendocrine neoplasms (NEN) may reflect tumor differentiation and thus be associated with prognosis. Non-invasive quantification of receptor density is possible by somatostatin receptor imaging (SRI) using positron emission tomography (PET).
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Carlsen E
Authors: Carlsen E, Johnbeck C, Binderup T, Loft M, Pfeifer A,
Keywords: 64Cu-dotatate, neuroendocrine neoplasm, progression-free survival, overall survival,
#2213 Imaging Modality Depending on the Levels of Tumor Markers
Introduction: 18 F-Fluorodihydroxyphenylalanine(18F)-FDOPA positron emission tomography (PET)/computed tomography (CT) has the advantage of being a noninvasive test and is by far the most promising imaging modality for neuroendocrine tumors (NETs).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Iorio J
Authors: Iorio J, Eleta M, Cuneo L, Polillo D, Peña F,
Keywords: neuroendocrine tumors, tumor marker, 18F-FDOPA, PET/CT,
Introduction: Predicting aggressive behavior of NF PNET still remains controversial. It is known that lymph node metastases are rare but possible also on small (1-2 cm) NF-PNET. Positive 18F-FDG-PET/CT avidity is associated with poor prognosis in NETs.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Kauhanen O
Authors: Majala S, Seppänen H, Kemppainen J, Arola J, Schalin-Jäntti C,
Keywords: pancreatic neuroendocrine tumors, nonfunctional, incidentaloma, positron emission tomography, diagnosis,